These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 8993605)

  • 1. Comparison of dose-response relationships for induction of lipid metabolizing and growth regulatory genes by peroxisome proliferators in rat liver.
    Belury MA; Moya-Camarena SY; Sun H; Snyder E; Davis JW; Cunningham ML; Vanden Heuvel JP
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):254-61. PubMed ID: 9707502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental studies on liver coenzyme A. II. Coenzyme A and pantothenic acid levels in the liver of the rats treated with carbon tetrachloride, DL-ethionine or partially hepatectomized.
    Kanematsu Y
    Naika Hokan; 1966 Mar; 13(3):133-7. PubMed ID: 6006116
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cell proliferation and toxicity in Sprague-Dawley rats.
    Chen H; Huang CY; Wilson MW; Lay LT; Robertson LW; Chow CK; Glauert HP
    Carcinogenesis; 1994 Dec; 15(12):2847-50. PubMed ID: 8001245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferators and signal transduction.
    Bronfman M; Nuñez L; Orellana A; Burzio V; Hidalgo P
    Ann N Y Acad Sci; 1996 Dec; 804():403-12. PubMed ID: 8993559
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic requirements for the hepatocellular proliferation induced by peroxisome proliferators. Role of coenzyme A.
    Youssef JA; Cunningham ML; Song WO; Badr MZ
    Ann N Y Acad Sci; 1996 Dec; 804():725-7. PubMed ID: 8993605
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanisms of rodent liver carcinogenesis.
    Michalopoulos GK; Eckl PM; Cruise JL; Novicki DL; Jirtle RL
    Toxicol Ind Health; 1987 Jun; 3(2):119-28. PubMed ID: 3303445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peroxisome proliferators and hepatocarcinogenesis].
    Tamura H
    Seikagaku; 1995 Aug; 67(8):1044-7. PubMed ID: 7594872
    [No Abstract]   [Full Text] [Related]  

  • 8. Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans.
    Reddy JK; Lalwai ND
    Crit Rev Toxicol; 1983; 12(1):1-58. PubMed ID: 6360536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relevance of peroxisome proliferation and cell proliferation in peroxisome proliferator-induced hepatocarcinogenesis.
    Rao MS; Reddy JK
    Drug Metab Rev; 1989; 21(1):103-10. PubMed ID: 2696631
    [No Abstract]   [Full Text] [Related]  

  • 10. [Peroxisome proliferation and possible cancer hazard].
    Dybing E; Sanner T
    Tidsskr Nor Laegeforen; 1995 Jun; 115(15):1839-41. PubMed ID: 7638833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferators: potential role of altered hepatocyte growth and differentiation in tumor development.
    Cattley RC; Miller RT; Corton JC
    Prog Clin Biol Res; 1995; 391():295-303. PubMed ID: 8532723
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.